Donkey anti goat IgG antibody recognizes goat immunoglobulin G. This antibody has been absorbed against human, rabbit, rat, horse, guinea pig, hamster, chicken and mouse to minimize naturally occurring cross reactivities.
- Target Species
- Product Form
- Purified IgG conjugated to Horseradish Peroxidase (HRP) - lyophilised
- Reconstitute with 0.5 ml distilled water
Care should be taken during reconstitution as the protein may appear as a film at the bottom of the vial. Bio-Rad recommend that the vial is gently mixed after reconstitution.
- Purified IgG prepared by affinity chromatography
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 1.5% Bovine Serum Albumin
- Approx. Protein Concentrations
- Please see label for concentration
- Prior to reconstitution store at +4oC.
After reconstitution store at -20oC.
Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody.
- 12 months from date of reconstitution.
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of IgG antibody
|Immunohistology - Frozen
|Immunohistology - Paraffin
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Useful Reagents Available
Application Based External Images
Immunohistology - Paraffin
Product Specific References
References for IgG antibody
Maas, C. et al. (2010) Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma.
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9083-7.
Rau, J.C.et al. (2009) Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
Exp Mol Pathol. 87: 178-83.
Guitton, C. et al. (2011) Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-κB, and ERK1/2 MAP kinases.
Am J Physiol Cell Physiol. 300: C833-42.
Elders, R.C. et al. (2014) Recombinant canine IgE Fc and an IgE Fc-TRAIL fusion protein bind to neoplastic canine mast cells.
Vet Immunol Immunopathol. 159 (1-2): 29-40.
Riesbeck, K. & Forsgren, A. (2016) Interaction of Moraxella catarrhalis with Epithelial Cells, Extracellular Matrix Proteins and the Complement System.
Patent Application Publication No. 20160318979
Tamarozzi, F. et al. (2014) A lack of confirmation with alternative assays questions the validity of IL-17A expression in human neutrophils using immunohistochemistry.
Immunol Lett. 162 (2 Pt B): 194-8.
Nicol, M.Q. et al. (2019) Lack of IFNγ signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis.
Virology. 526: 155-64.